Patents by Inventor Catherine Mace
Catherine Mace has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140044830Abstract: An infant formula comprising at least a source of proteins, a source of lipids, a source of carbohydrates, wherein the protein content is below 2.1 g/100 kcal, for use in the prevention of cardiovascular diseases, in particular for the prevention of cardiovascular diseases associated with high blood pressure. Preferably said composition is a starter infant formula.Type: ApplicationFiled: April 17, 2012Publication date: February 13, 2014Applicant: NESTEC S.A.Inventors: Catherine Mace, Phillippe Steenhout
-
Patent number: 8591880Abstract: The present invention relates to supporting weight management, weight loss and/or to the prevention and/or treatment of metabolic disorders. In particular the present invention relates to preventing and/or treating metabolic disorders by modulating, in particular reducing the amount of proteobacteria and/or deferribacteres in the gut. One embodiment of the present invention relates to the use of a primary composition comprising an agent that reduces the amount of proteobacteria, preferably gamma-proteobacteria, even more preferred enterobacteria; and/or deferribacteres in the gut for the preparation of a composition to treat or prevent metabolic disorders, to support weight loss and/or to support weight management.Type: GrantFiled: July 25, 2008Date of Patent: November 26, 2013Assignee: Nestec S.A.Inventors: Chieh Jason Chou, David Philippe, Christian Darlmont, Fabrizio Arigoni, Catherine Mace
-
Patent number: 8586077Abstract: A nutritional composition for infants comprises a protein source, a lipid source and a carbohydrate source wherein the lipid source includes at least 16 wt % linoleic acid and at least 2 wt % ?-linolenic acid expressed as a percentage of total fatty acid content in each case and in amounts such that the ratio of linoleic acid:?-linolenic acid is in the range from 1 to 10.Type: GrantFiled: December 16, 2009Date of Patent: November 19, 2013Assignee: Nestec S.A.Inventors: Catherine Mace, Olivier Kevork Aprikian, Etienne Pouteau
-
Publication number: 20130296428Abstract: A nutritional composition comprising a significant amount of arachidonic acid (ARA) is described. Such nutritional composition is particularly suitable for infants below the age of 3 years, preferably between birth and 12 months of life. The composition can be used to reduce the risk of developing overweight/obesity and/or insulin resistance later in life.Type: ApplicationFiled: April 9, 2013Publication date: November 7, 2013Inventors: Catherine Mace, Olivier Aprikian
-
Patent number: 8454949Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus helveticus CNCM I-4095 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: GrantFiled: February 4, 2010Date of Patent: June 4, 2013Assignee: Nestec S.A.Inventors: Fabrizio Arigoni, Christian Darimont-Nicolau, Catherine Mace
-
Patent number: 8440178Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to treat obesity. One embedment of the present invention relates to the use of Lactobacillus rhamnosus CGMCC 1.3724 and/or Lactobacillus rhamnosus NCC 4007 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: GrantFiled: July 24, 2008Date of Patent: May 14, 2013Assignee: Nestec S.A.Inventors: Christian Darimont, David Philippe, Catherine Mace, Fabrizio Arigoni
-
Patent number: 8318150Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus rhamnosus CNCM I-4096 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: GrantFiled: February 4, 2010Date of Patent: November 27, 2012Assignee: Nestec S.A.Inventors: Fabrizio Arigoni, Christian Darimont-Nicolau, Catherine Mace
-
Patent number: 8318151Abstract: The present invention generally relates to the field of weight management and obesity. In particular the present invention relates to the use of probiotics in combination with prebiotics to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus rhamnosus NCC 4007 in combination with a specific probiotic mixture for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: GrantFiled: February 4, 2010Date of Patent: November 27, 2012Assignee: Nestec S.A.Inventors: Christian Darimont-Nicolau, David Philippe, Catherine Mace, Fabrizio Arigoni
-
Publication number: 20120114622Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to treat obesity. One embedment of the present invention relates to the use of Lactobacillus rhamnosus CGMCC 1.3724 and/or Lactobacillus rhamnosus NCC 4007 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: ApplicationFiled: July 24, 2008Publication date: May 10, 2012Applicant: NESTEC S.A.Inventors: Christian Darimont, David Philippe, Catherine Mace, Fabrizio Arigoni
-
Publication number: 20120039852Abstract: The present invention generally relates to the field of weight management and obesity. In particular the present invention relates to the use of probiotics in combination with prebiotics to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus rhamnosus NCC 4007 in combination with a specific probiotic mixture for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: ApplicationFiled: February 4, 2010Publication date: February 16, 2012Applicant: NESTEC S.A.Inventors: Christian Darimont-Nicolau, David Philippe, Catherine Mace, Fabrizio Arigoni
-
Publication number: 20120029080Abstract: A nutritional composition comprising a significant amount of arachidonic acid (ARA) is described. Such nutritional composition is particularly suitable for infants below the age of 3 years, preferably between birth and 12 months of life. The composition can be used to reduce the risk of developing overweight/obesity and/or insulin resistance later in life.Type: ApplicationFiled: March 26, 2010Publication date: February 2, 2012Applicant: NESTEC S.A.Inventors: Catherine Mace, Olivier Aprikian
-
Publication number: 20120021977Abstract: The use of a protein source comprising bovine casein proteins for the preparation of a nutrional composition for administration to an infant, young child or adult during or after a period of catch-up growth or weight recovery, following a period of growth restriction or weight lost, so as improve growth at early age and/or to reduce the risk of development of insulin resistance and/or Type 2 diabetes later in the life of the infant, young child or adult.Type: ApplicationFiled: March 26, 2010Publication date: January 26, 2012Applicant: NESTEC S.A.Inventors: Olivier Aprikian, Florence Blancher, Catherine Mace, Yassaman Shahkhalili
-
Publication number: 20120004163Abstract: A nutritional composition for infants comprises a protein source, a lipid source and a carbohydrate source wherein the lipid source includes at least 16 wt % linoleic acid and at least 2 wt % ?-linolenic acid expressed as a percentage of total fatty acid content in each case and in amounts such that the ratio of linoleic acid:?-linolenic acid is in the range from 1 to 10.Type: ApplicationFiled: December 16, 2009Publication date: January 5, 2012Applicant: NESTEC S.A.Inventors: Catherine Mace, Olivier Kevork Aprikian, Etienne Pouteau
-
Publication number: 20110293568Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus helveticus CNCM I-4095 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: ApplicationFiled: February 4, 2010Publication date: December 1, 2011Applicant: NESTEC S.A.Inventors: Fabrizio Arigoni, Christian Darimont-Nicolau, Catherine Mace
-
Publication number: 20110293569Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus rhamnosus CNCM I-4096 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: ApplicationFiled: February 4, 2010Publication date: December 1, 2011Applicant: NESTEC S.A.Inventors: Fabrizio Arigoni, Christian Darimont-Nicolau, Catherine Mace
-
Publication number: 20110244072Abstract: A method of reducing the accumulation of fat mass in a neonatal human infant at risk thereof which method comprises administering to the infant during at least a part of the neonatal period a therapeutic amount of a nutritional composition comprising proteins in an amount such that the composition contains more than 2.4 g of protein per 100 kcal. As weight gain during the first week of life has been associated with overweight in adulthood, this may offer a method of reducing the risk of developing obesity in later life. Also claimed is the administration of DHA to the mother during gestation period.Type: ApplicationFiled: November 23, 2009Publication date: October 6, 2011Applicant: NESTEC S.A.Inventors: Marie-Claire Fichot, Catherine Mace, Philippe Steenhout
-
Patent number: 8012509Abstract: The present invention pertains to nutritional and pharmaceutical compositions for treating and preventing cyclooxygenase-2 mediated diseases and to a process for increasing the cyclooxygenase-2 inhibiting activity of a product. In addition thereto, the present invention relates to the use of one ore more milk protein fractions and/or one ore more milk protein preparations for inhibiting the activity of cyclooxygenase-2 (COX-2), in particular for the preparation of a medicament or a functional food for treating and preventing cyclooxygenase-2 mediated diseases.Type: GrantFiled: September 13, 2004Date of Patent: September 6, 2011Assignee: Nestec S.A.Inventors: Lionel Bovetto, Joerg Hau, Catherine Mace
-
Publication number: 20110201462Abstract: The invention relates to a string for a racket, particularly for a tennis racket, which includes: a central core (2) and a peripheral protective layer (6). Additionally, the string includes an intermediate reinforcing layer (4) made of a composite material and placed between the central core (2) and the peripheral protective layer (6), the hardness of the reinforcing layer (4; 14; 24; 34) being greater than the hardness of the protective layer (6; 16; 26; 36), the reinforcing layer providing a function of increasing the resistance to wear and tear, while the protective layer provides a function of increasing sliding.Type: ApplicationFiled: August 11, 2009Publication date: August 18, 2011Applicant: BABOLAT VSInventors: Jean-Philippe Onnis, Catherine Mace
-
Publication number: 20110123501Abstract: The present invention relates to supporting weight management, weight loss and/or to the prevention and/or treatment of metabolic disorders. In particular the present invention relates to preventing and/or treating metabolic disorders by modulating, in particular reducing the amount of proteobacteria and/or deferribacteres in the gut. One embodiment of the present invention relates to the use of a primary composition comprising an agent that reduces the amount of proteobacteria, preferably gamma-proteobacteria, even more preferred enterobacteria; and/or deferribacteres in the gut for the preparation of a composition to treat or prevent metabolic disorders, to support weight loss and/or to support weight management.Type: ApplicationFiled: July 25, 2008Publication date: May 26, 2011Applicant: NESTEC S.A.Inventors: Chieh Jason Chou, David Philippe, Christian Darimont, Fabrizio Arigoni, Catherine Mace
-
Publication number: 20110002900Abstract: The present invention relates in general to medium chain dicarboxylic acids, their derivatives and their uses. In particular, the present invention relates to a composition comprising medium chain dicarboxylic acids and to the use of medium chain dicarboxylic acids and their derivatives for the preparation of products to treat or prevent metabolic disorders. The composition of the present invention can particularly well be used to treat or prevent hyperglycemia, for example diabetes.Type: ApplicationFiled: March 9, 2009Publication date: January 6, 2011Inventors: Geltrude Mingrone, Catherine Mace